France Animal Vaccine Market to Reach $23,604.7 million in 2035, Growing at 6.8% CAGR

France Animal vaccine market valued at $12,306.8 million in 2025 and is projected to reach $23,604.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The market encompasses vaccines developed for livestock, poultry, companion animals, aquaculture, and other animal species. Key vaccine technologies include live attenuated vaccines, killed/inactivated vaccines, recombinant vaccines, DNA vaccines, and subunit vaccines, supported by species-specific formulations and dosing. The market is witnessing steady growth driven by the rising burden of animal diseases, government-mandated vaccination programs, increasing pet ownership, and a growing focus on preventive animal healthcare. Expansion is further supported by regulatory incentives for animal vaccine development, investments by pharmaceutical and biotechnology companies in veterinary research, and technological advancements in recombinant and combination vaccines. Increased prevalence of livestock and poultry diseases, along with rising awareness of pet health, is reinforcing long-term market demand.

Browse the full report description of “France Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/france-animal-vaccine-market

According to data from France’s Ministry of Agriculture and major veterinary associations, routine vaccination campaigns against common livestock and poultry diseases, along with companion animal immunization programs, have strengthened disease control and prevention strategies. National surveillance and reporting platforms provide critical data for estimating vaccine demand, therapeutic utilization, and long-term animal healthcare needs in France.

Key Data: France Animal Vaccines at a Glance

• National vaccination programs in France cover major livestock diseases such as lumpy skin disease, foot-and-mouth disease, and avian influenza, forming the foundation of preventive veterinary healthcare.
• France has millions of animals under routine vaccination coverage, representing the core addressable population for animal vaccines.
• Companion animal vaccines are increasingly adopted, supported by rising pet ownership and preventive care awareness.

Key Innovators Driving France Animal Vaccine Transformation

The key players in the France animal vaccine market include Elanco Animal Health Incorporated, Merck & Co., Inc., Vetoquinol S.A., Virbac S.A., Zoetis Inc, among others.

• In May 2025, Virbac expanded its production capacity in France to support its companion animal vaccine portfolio, addressing increasing demand in domestic and broader European markets.
• In March 2025, Ceva Santé Animale advanced research initiatives focused on next-generation recombinant vaccines targeting emerging livestock diseases, reinforcing France’s position as a key innovation hub in veterinary biologics.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Elanco Animal Health Incorporated, Merck & Co., Inc., Vetoquinol S.A., Virbac S.A., Zoetis Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

France Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/france-animal-vaccine-market